Efficacy and safety of CyberKnife radiosurgery for acromegaly

Pituitary

Volumn 10, Issue 1, 2007, Pages 19-25

  Roberts, Brian K ^a   Ouyang, Daniel L ^a   Lad, Shivanand P ^a   Chang, Steven D ^a   Harsh, Griffith R ^a   Adler Jr , John R ^a   Soltys, Scott G ^a   Gibbs, Iris C ^a   Katznelson, Laurence ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD CANCER INSTITUTE   (United States)

Author keywords

Acromegaly; Cyberknife; Pituitary; Radiosurgery; Stereotactic

Indexed keywords

SOMATOMEDIN C;

ACROMEGALY; ADULT; ARTICLE; FEMALE; GROWTH HORMONE SECRETING ADENOMA; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RADIOSURGERY; RETROSPECTIVE STUDY;

ACROMEGALY; ADULT; FEMALE; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RADIOSURGERY; RETROSPECTIVE STUDIES;

EID: 34447549877     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-007-0004-3     Document Type: Article

References (40)

1. Katznelson L (2005) Diagnosis and treatment of acromegaly. Growth Horm IGF Res 15(Suppl A):S31-35 (Pubitemid 41030769)
2. Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB (1998) Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 83:3411-3418 (Pubitemid 28500865)
3. Swearingen B, Barker FG 2nd, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zervas NT (1998) Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 83:3419-3426 (Pubitemid 28500866)
4. Ahmed S, Elsheikh M, Stratton IM, Page RC, Adams CB, Wass JA (1999) Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol (Oxf) 50:561-567 (Pubitemid 29236331)
5. Shimon I, Cohen ZR, Ram Z, Hadani M (2001) Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery 48:1239-1243; discussion 1244-1245
6. AACE Medical Guidelines for Clinical Practice for the diagnosis and treatment of acromegaly. Endocr Pract (2004) 10:213-225
7. Barkan AL, Halasz I, Dornfeld KJ, Jaffe CA, Friberg RD, Chandler WF, Sandler HM (1997) Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. J Clin Endocrinol Metab 82:3187-3191 (Pubitemid 27419054)
8. Barkan AL (2003) Radiotherapy in acromegaly: the argument against. Clin Endocrinol (Oxf) 58:132-135 (Pubitemid 36194264)
9. Barrande G, Pittino-Lungo M, Coste J, Ponvert D, Bertagna X, Luton JP, Bertherat J (2000) Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center. J Clin Endocrinol Metab 85:3779-3785
10. Biermasz NR, van Dulken H, Roelfsema F (2000) Longterm follow-up results of postoperative radiotherapy in 36 patients with acromegaly. J Clin Endocrinol Metab 85:2476-2482 (Pubitemid 32269203)
11. Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, Wellis G (1998) Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy. J Neurosurg 88:1002-1008 (Pubitemid 28261846)
12. Adler JR Jr, Murphy MJ, Chang SD, Hancock SL (1999) Image-guided robotic radiosurgery. Neurosurgery 44:1299-1306; discussion 1306-1307
13. Chang SD, Main W, Martin DP, Gibbs IC, Heilbrun MP (2003) An analysis of the accuracy of the CyberKnife: a robotic frameless stereotactic radiosurgical system. Neurosurgery 52:140-146; discussion 146-147
14. Fowler JF (1992) Brief summary of radiobiological principles in fractionated radiotherapy. Semin Radiat Oncol 2:16-21
15. Hall EJ, Brenner DJ (1993) The radiobiology of radiosurgery: rationale for different treatment regimes for AVMs and malignancies. Int J Radiat Oncol Biol Phys 25:381-385 (Pubitemid 23048798)
16. Shrieve DC, Klish M, Wendland MM, Watson GA (2004) Basic principles of radiobiology, radiotherapy, and radiosurgery. Neurosurg Clin N Am 15:467-479 (Pubitemid 39278442)
17. Cozzi R, Barausse M, Asnaghi D, Dallabonzana D, Lodrini S, Attanasio R (2001) Failure of radiotherapy in acromegaly. Eur J Endocrinol 145:717-726 (Pubitemid 33133678)
18. Powell JS, Wardlaw SL, Post KD, Freda PU (2000) Outcome of radiotherapy for acromegaly using normalization of insulin-like growth factor I to define cure. J Clin Endocrinol Metab 85:2068-2071 (Pubitemid 32269321)
19. Melmed S, Ho K, Klibanski A, Reichlin S, Thorner M (1995) Clinical review 75: recent advances in pathogenesis, diagnosis, and management of acromegaly. J Clin Endocrinol Metab 80:3395-3402
20. Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK (1994) Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf) 41:95-102 (Pubitemid 24232533)
21. Atkinson AB, Allen IV, Gordon DS, Hadden DR, Maguire CJ, Trimble ER, Lyons AR (1979) Progressive visual failure in acromegaly following external pituitary irradiation. Clin Endocrinol (Oxf) 10:469-479 (Pubitemid 10168384)
22. Brada M, Ford D, Ashley S, Bliss JM, Crowley S, Mason M, Rajan B, Traish D (1992) Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ 304:1343-1346
23. Brada M, Rajan B, Traish D, Ashley S, Holmes-Sellors PJ, Nussey S, Uttley D (1993) The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol (Oxf) 38:571-578 (Pubitemid 23168470)
24. Gittoes NJ, Bates AS, Tse W, Bullivant B, Sheppard MC, Clayton RN, Stewart PM (1998) Radiotherapy for nonfunction pituitary tumours. Clin Endocrinol (Oxf) 48: 331-337
25. Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML (1989) Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q J Med 70:145-160 (Pubitemid 19115954)
26. McCollough WM, Marcus RB Jr, Rhoton AL Jr, Ballinger WE, Million RR (1991) Long-term follow-up of radiotherapy for pituitary adenoma:the absence of late recurrence after greater than or equal to 4500 cGy. Int J Radiat Oncol Biol Phys 21:607-614
27. McCord MW, Buatti JM, Fennell EM, Mendenhall WM, Marcus RB Jr, Rhoton AL, Grant MB, Friedman WA (1997) Radiotherapy for pituitary adenoma: long-term outcome and sequelae. Int J Radiat Oncol Biol Phys 39:437-444
28. Simmons NE, Laws ER Jr (1998) Glioma occurrence after sellar irradiation: case report and review. Neurosurgery 42:172-178 (Pubitemid 28067041)
29. Tsang RW, Brierley JD, Panzarella T, Gospodarowicz MK, Sutcliffe SB, Simpson WJ (1994) Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors. Int J Radiat Oncol Biol Phys 30:557-565 (Pubitemid 24304466)
30. Zierhut D, Flentje M, Adolph J, Erdmann J, Raue F, Wannenmacher M (1995) External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys 33:307-314
31. Swords FM, Allan CA, Plowman PN, Sibtain A, Evanson J, Chew SL, Grossman AB, Besser GM, Monson JP (2003) Stereotactic radiosurgery XVI: a treatment for previously irradiated pituitary adenomas. J Clin Endocrinol Metab 88:5334-5340 (Pubitemid 37452736)
32. Castinetti F, Taieb D, Kuhn JM, Chanson P, Tamura M, Jaquet P, Conte-Devolx B, Regis J, Dufour H, Brue T (2005) Outcome of gamma knife radiosurgery in 82 patients with acromegaly:correlation with initial hypersecretion. J Clin Endocrinol Metab 90:4483-4488 (Pubitemid 41159330)
33. Attanasio R, Epaminonda P, Motti E, Giugni E, Ventrella L, Cozzi R, Farabola M, Loli P, Beck-Peccoz P, Arosio M (2003) Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study. J Clin Endocrinol Metab 88:3105-3112 (Pubitemid 36877479)
34. Gutt B, Wowra B, Alexandrov R, Uhl E, Schaaf L, Stalla GK, Schopohl J (2005) Gamma-knife surgery is effective in normalising plasma insulin-like growth factor I in patients with acromegaly. Exp Clin Endocrinol Diabetes 113:219-224 (Pubitemid 40695328)
35. Motti ED, Losa M, Pieralli S, Zecchinelli A, Longobardi B, Giugni E, Ventrella L (1996) Stereotactic radiosurgery of pituitary adenomas. Metabolism 45:111-114
36. Pollock BE, Kondziolka D, Lunsford LD, Flickinger JC (1994) Stereotactic radiosurgery for pituitary adenomas: imaging, visual and endocrine results. Acta Neurochir. Suppl 62:33-38
37. Zhang N, Pan L, Wang EM, Dai JZ, Wang BJ, Cai PW (2000) Radiosurgery for growth hormone-producing pituitary adenomas. J Neurosurg 93(Suppl 3):6-9 (Pubitemid 32799536)
38. Kajiwara K, Saito K, Yoshikawa K, Kato S, Akimura T, Nomura S, Ishihara H, Suzuki M (2005) Image-guided stereotactic radiosurgery with the CyberKnife for pituitary adenomas. Minim Invasive Neurosurg 48:91-96 (Pubitemid 40769554)
39. Sheehan JP, Niranjan A, Sheehan JM, Jane JA Jr, Laws ER, Kondziolka D, Flickinger J, Landolt AM, Loeffler JS, Lunsford LD (2005) Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 102:678-691 (Pubitemid 43186673)
40. Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, Wellis G (2000) Octreotide may act as a radioprotective agent in acromegaly. J Clin Endocrinol Metab 85:1287-1289 (Pubitemid 32269387)